Lista de obras - Ingo Kleiter - Dominio Público Uruguay

A lightning strike to the head causing a visual cortex defect with simple and complex visual hallucinations

artículo científico publicado en 2007

Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation

artículo científico publicado en 2015

Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study

artículo científico publicado en 2017

Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome

artículo científico publicado en 2016

Analysis of neurogenesis during experimental autoimmune encephalomyelitis reveals pitfalls of bioluminescence imaging

artículo científico publicado en 2015

Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions

Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses

artículo científico publicado en 2010

Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS.

artículo científico publicado en 2017

Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate

artículo científico publicado en 2014

Author response: Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders

artículo científico publicado en 2020

Autonomic and peripheral nervous system function in acute tick-borne encephalitis

artículo científico publicado en 2016

Autonomic involvement in tick-borne encephalitis (TBE): report of five cases.

artículo científico publicado en 2006

Benefit-risk perception of natalizumab therapy in neurologists and a large cohort of multiple sclerosis patients

artículo científico publicado en 2017

Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?

artículo científico

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients

scientific article published on 03 September 2020

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

artículo científico publicado en 2012

Correspondence (letter to the editor): Effects on the Nervous System

artículo científico publicado en 2008

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients

artículo científico publicado en 2013

Early changes on electroencephalography in natalizumab-associated progressive multifocal leucoencephalopathy

artículo científico publicado en 2010

Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study

artículo científico publicado en 2016

Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming.

artículo científico publicado en 2016

Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations

artículo científico publicado en 2016

Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis ⬇️

artículo científico publicado el 25 de diciembre de 2012

Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease

artículo científico publicado en 2012

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

artículo científico publicado en 2017

Influence of female sex and fertile age on neuromyelitis optica spectrum disorders

artículo científico publicado en 2016

Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy ⬇️

artículo científico publicado el 1 de marzo de 2013

Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology

artículo científico publicado en 2020

Is It Too Early to Predict the Failure of Natalizumab in NMO?—Reply

Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?

artículo científico publicado en 2017

Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder

artículo científico publicado en 2015

Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders

artículo científico publicado en 2019

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

artículo científico publicado en 2016

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

artículo científico publicado en 2016

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome

artículo científico publicado en 2016

Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease

artículo científico publicado en 2012

Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease ⬇️

artículo científico publicado el 15 de septiembre de 2010

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses

artículo científico publicado en 2015

Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis

artículo científico publicado en 2008

Numeracy of multiple sclerosis patients: A comparison of patients from the PERCEPT study to a German probabilistic sample

artículo científico publicado en 2017

Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma

artículo científico publicado en 2004

Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy

artículo científico publicado en 2016

Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders

artículo científico publicado en 2015

Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy

artículo científico publicado en 2014

Relevance of endoglin, IL-1α, IL-1β and anti-ovarian antibodies in females with multiple sclerosis

artículo científico publicado en 2016

Retinal Involvement in a Patient with Cerebral Manifestation of Chronic Graft-Versus-Host-Disease

artículo científico publicado en 2015

Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis

artículo científico publicado en 2017

Serum anti-Müllerian hormone levels in reproductive-age women with relapsing-remitting multiple sclerosis

artículo científico publicado en 2014

Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis

artículo científico publicado en 2010

Smad7 in intestinal CD4+ T cells determines autoimmunity in a spontaneous model of multiple sclerosis

scientific article published on 03 December 2019

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.

artículo científico publicado en 2015

TGF-β inhibitor Smad7 regulates dendritic cell-induced autoimmunity.

artículo científico publicado en 2017

Update on biomarkers in neuromyelitis optica

artículo científico publicado en 2015

Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

artículo científico publicado en 2013

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder

artículo científico publicado en 2015

Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.

artículo científico publicado en 2015

Visual evoked potentials in neuromyelitis optica and its spectrum disorders

artículo científico publicado en 2013

Lista de obras de Ingo Kleiter

A lightning strike to the head causing a visual cortex defect with simple and complex visual hallucinations

Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation

Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study

Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome

Analysis of neurogenesis during experimental autoimmune encephalomyelitis reveals pitfalls of bioluminescence imaging

Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions

Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses

Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS.

Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate

Author response: Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders

Autonomic and peripheral nervous system function in acute tick-borne encephalitis

Autonomic involvement in tick-borne encephalitis (TBE): report of five cases.

Benefit-risk perception of natalizumab therapy in neurologists and a large cohort of multiple sclerosis patients

Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

Correspondence (letter to the editor): Effects on the Nervous System

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients

Early changes on electroencephalography in natalizumab-associated progressive multifocal leucoencephalopathy

Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study

Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming.

Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations

Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis ⬇️

Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

Influence of female sex and fertile age on neuromyelitis optica spectrum disorders

Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy ⬇️

Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology

Is It Too Early to Predict the Failure of Natalizumab in NMO?—Reply

Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?

Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder

Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome

Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease

Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease ⬇️

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses

Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis

Numeracy of multiple sclerosis patients: A comparison of patients from the PERCEPT study to a German probabilistic sample

Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma

Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy

Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders

Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy

Relevance of endoglin, IL-1α, IL-1β and anti-ovarian antibodies in females with multiple sclerosis

Retinal Involvement in a Patient with Cerebral Manifestation of Chronic Graft-Versus-Host-Disease

Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis

Serum anti-Müllerian hormone levels in reproductive-age women with relapsing-remitting multiple sclerosis

Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis

Smad7 in intestinal CD4+ T cells determines autoimmunity in a spontaneous model of multiple sclerosis

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.

TGF-β inhibitor Smad7 regulates dendritic cell-induced autoimmunity.

Update on biomarkers in neuromyelitis optica

Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder

Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.

Visual evoked potentials in neuromyelitis optica and its spectrum disorders